Cargando…
Synergistic effects of bevacizumab in combination with β-elemene on subcutaneous xenografts derived from HCT-116 human colon cancer cells
BACKGROUND: To observe the effect of bevacizumab in combination with β-elemene on subcutaneous xenografts established from HCT-116 human colon cancer cells, explore the underlying mechanisms involved, and provide more options for the treatment of advanced colorectal cancer. METHODS: Mice were random...
Autores principales: | Li, Jin-Na, Xie, Feng, Wang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798753/ https://www.ncbi.nlm.nih.gov/pubmed/35117445 http://dx.doi.org/10.21037/tcr.2019.12.35 |
Ejemplares similares
-
In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model
por: Threatt, Stephanie D., et al.
Publicado: (2020) -
A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer
por: Maradonna, Francesca, et al.
Publicado: (2022) -
Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric
por: Prasad, Sahdeo, et al.
Publicado: (2017) -
Hyperforin and Myrtucommulone Derivatives Act as Natural Modulators of Wnt/β-Catenin Signaling in HCT116 Colon Cancer Cells
por: Knauthe, Aneliya, et al.
Publicado: (2022) -
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells
por: Sabit, Hussein, et al.
Publicado: (2016)